1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with myricetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broedel, SE; Cihlar, RL; ElSohly, HN; Ferreira, D; Jacob, MR; Joshi, AS; Khan, IA; Khan, SI; Li, XC; Raulli, RE; Walker, LA; Zhang, Z | 1 |
| Bazinet, L; Cao, S; Christensen, KA; Clardy, J; Cryan, LM; Habeshian, KA; Rogers, MS | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and myricetin
| Article | Year |
|---|---|
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
Topics: Antifungal Agents; Candida albicans; Combretaceae; Cryptococcus neoformans; Enzyme Inhibitors; Fatty Acid Synthases; Inhibitory Concentration 50; Isoflavones; Melastomataceae; Molecular Structure; Moraceae; Paspalum; Plants, Medicinal; Saccharomyces cerevisiae; Structure-Activity Relationship; Tannins; Triterpenes | 2002 |
1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Humans; Hydrolyzable Tannins; Mice; Neovascularization, Pathologic; Receptors, Peptide | 2013 |